1-6 of 6
Murali Kesavan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained clinical benefit of glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab plus GemOx (R-GemOx) in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): 3-year follow-up of STARGLO

Free
Jeremy Abramson, Matthew Ku, Christopher Fox, Huiqiang Huang, Huilai Zhang, William Townsend, Dok Hyun Yoon, Won-Seog Kim, Haifaa Abdulhaq, Charles Herbaux, Jan Zaucha, Hung Chang, Estefania Mulvihill, Murali Kesavan, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Alessia Bottos, Linda Lundberg, Gareth P. Gregory
Journal: Blood
Blood (2025) 146 (Supplement 1): 5519.
https://doi.org/10.1182/blood-2025-5519
Published: 2025
Journal Articles

Glofitamab plus gemcitabine and oxaliplatin (GemOx) vs rituximab (R)-GemOx in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Efficacy and safety in patient subgroups

Free
Haifaa Abdulhaq, William Townsend, Matthew Ku, Gareth P. Gregory, Jeremy Abramson, Huiqiang Huang, Huilai Zhang, Dok Hyun Yoon, Won-Seog Kim, Herve Ghesquieres, Mark Hertzberg, Qing-Yuan Zhang, Murali Kesavan, Estefania Mulvihill, Martine Joanna Kallemeijn, Richard Ta, Voleak Choeurng, Linda Lundberg, Christopher Fox
Journal: Blood
Blood (2025) 146 (Supplement 1): 3743.
https://doi.org/10.1182/blood-2025-3743
Published: 2025
Journal Articles

Final Analysis of the Safety and Efficacy of Venetoclax in Combination with Pola-R-CHP for Untreated High-Risk BCL-2-Positive B-Cell Lymphoma Including Double/Triple Hit Lymphoma

Free
Catherine S. Diefenbach, Andrew D. Zelenetz, Charles Herbaux, Monica Tani, Roch Houot, Mariana Bastos-Oreiro, Hervé Tilly, Thomas Gastinne, Catherine Thieblemont, Wilfred Leung, Katerina Hatzi, Murali Kesavan, Simona Barlera, Michelle Boyer, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 577.
https://doi.org/10.1182/blood-2024-198624
Published: 2024
Journal Articles

Deep Learning Predicts Risk of Large B-Cell Lymphoma Progression upon R-CHOP Therapy from Baseline Histology

Free
Samaneh Abbasi Sureshjani, Anil Yüce, Christian Doerig, Agata Mosinska, Patrick Kimes, Murali Kesavan, Connie Lee Batlevi, Yanwen Jiang, Markus D Herrmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 108.
https://doi.org/10.1182/blood-2024-203029
Published: 2024
Journal Articles

Early Results Indicate Acceptable Safety and Promising Efficacy of Venetoclax in Combination with Pola-R-CHP for Untreated High-Risk BCL-2-Positive B-Cell Lymphoma Including Double/Triple Hit Lymphoma

Free
Andrew D. Zelenetz, Catherine S. Diefenbach, Charles Herbaux, Monica Tani, Roch Houot, Mariana Bastos-Oreiro, Herve Tilly, Thomas Gastinne, Catherine Thieblemont, Ethan Troy-Barnes, Stefano Olivieri, Murali Kesavan, Manisha Kanwar, Simona Barlera, Katerina Hatzi, Yanwen Jiang, Michelle Boyer, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 439.
https://doi.org/10.1182/blood-2023-174855
Published: 2023
Journal Articles

CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement

Free
Toby A. Eyre, Nicolas Martinez-Calle, MD #, Amy A Kirkwood, MSc, Catherine Hildyard, Murali Kesavan, Joseph Butler, Carolyn Mercer, Faouzi Djebbari, Hannah Plaschkes, John Griffith, Stephen Booth, Andrew McMillan, Mark Bishton, Christopher P. Fox, MD PhD, Graham P. Collins, MB BS DPhil, Chris Hatton
Journal: Blood
Blood (2018) 132 (Supplement 1): 1694.
https://doi.org/10.1182/blood-2018-99-111010
Published: 2018